Avanos Medical, Inc.
AVNS
$13.11
-$0.01-0.08%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 180.90M | 177.80M | 175.00M | 167.50M | 179.60M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 180.90M | 177.80M | 175.00M | 167.50M | 179.60M |
| Cost of Revenue | 94.90M | 91.80M | 82.90M | 77.70M | 81.60M |
| Gross Profit | 86.00M | 86.00M | 92.10M | 89.80M | 98.00M |
| SG&A Expenses | 89.40M | 77.20M | 83.50M | 75.70M | 93.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -1.40M | 2.30M | 300.00K | -1.60M | 2.10M |
| Total Operating Expenses | 177.30M | 177.30M | 172.50M | 157.20M | 169.10M |
| Operating Income | 3.60M | 500.00K | 2.50M | 10.30M | 10.50M |
| Income Before Tax | 1.20M | -1.20M | -75.90M | 9.70M | -420.50M |
| Income Tax Expenses | 2.50M | 200.00K | 900.00K | 3.10M | -23.50M |
| Earnings from Continuing Operations | -1.30M | -1.40M | -76.80M | 6.60M | -397.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -300.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.30M | -1.40M | -76.80M | 6.60M | -397.30M |
| EBIT | 3.60M | 500.00K | 2.50M | 10.30M | 10.50M |
| EBITDA | 13.50M | 9.90M | 12.50M | 19.90M | 21.60M |
| EPS Basic | -0.03 | -0.03 | -1.66 | 0.14 | -8.64 |
| Normalized Basic EPS | 0.03 | -0.01 | 0.01 | 0.13 | 0.12 |
| EPS Diluted | -0.03 | -0.03 | -1.66 | 0.14 | -8.64 |
| Normalized Diluted EPS | 0.03 | -0.01 | 0.01 | 0.13 | 0.12 |
| Average Basic Shares Outstanding | 46.40M | 46.40M | 46.30M | 46.10M | 46.00M |
| Average Diluted Shares Outstanding | 46.40M | 46.40M | 46.30M | 46.80M | 46.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |